Table 3 Treatment Administration
Dose Group 1 | Dose Group 2 | ||
|---|---|---|---|
Safety Population | 2000/10 mg | 2500/10 mg | Total |
No. of Patients | 13 | 6 | 19 |
Total No. of Cycles Administered | 56 | 23 | 79 |
Median No. of Cycles per Patient (Range) | 4 (1−14) | 3.5 (1−7) | 4 (1−14) |
No. of Cycles with Dose Reduction (% of total cycles) | 4 (7) | 3 (13) | 7 (9) |
No. of Cycles with Dose Delay (% of total cycles) | 7 (13) | 3 (13) | 10 (13) |